Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Auction house Christie’s has agreed to buy Gooding and Company, a classic auto auction house, to expand its luxury offerings.
McDonald’s announced that its $5 summer meal deal, which was only supposed to last through June, will now be extended into December.
Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The Gym Group announced on Wednesday that in the first six months of this year it swung back to a profit for the first time since 2019.
With rising valuations, sports team ownership should be a slam dunk. But it’s also possible those valuations are a little rich.
Elliott Management ousted much of the board at Southwest Airlines, with Gary Kelly announcing his retirement amid broader board turnover.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
On Monday, the Murdoch family was once again asked the $15 billion question: Who will take over the company after Rupert is no longer around?
While this could create a lucrative new revenue stream for Ford, it also presents a privacy conundrum, one expert said.
Boeing reached a tentative deal with the union representing its production workers in Washington state, likely dodging a strike.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.